News
07-12-2011, 01:10 AM
Sunshine Biopharma Inc. (OTCBB: SBFM), a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it has completed a detailed cytotoxicity study of its lead compound, Adva-27a, in MCF-7/MDR, a Multidrug Resistant Breast Cancer cell line...
More... (http://www.medicalnewstoday.com/releases/230861.php)
More... (http://www.medicalnewstoday.com/releases/230861.php)